#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Inborn error of metabolism Acquired haemophilia Eosinophilic oesophagitis Infantile spasms Thymic carcinoma Leiomyosarcoma metastatic Pemphigoid Short-bowel syndrome Gastrointestinal stromal tumour Optic glioma Dementia Alzheimer's type Adult T-cell lymphoma/leukaemia refractory Neuronal ceroid lipofuscinosis Alexander disease Homocystinuria More trials…

    Learn about Rare Diseases

    Lysosomal storage disorder – Treatment Burkitt’s lymphoma – Diagnostics Encephalitis autoimmune – Trials in Disease Prolymphocytic leukaemia – Trials in Disease Congenital hypotransferrinaemia – Treatment Alexander disease – Treatment Primary mediastinal large B-cell lymphoma Undifferentiated sarcoma – Treatment Metachromatic leukodystrophy – Trials in Disease Medulloblastoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lt3001 Dapirolizumab Pegol Benzocaine Rezvilutamide VINBLASTINE Lymecycline ULTEVURSEN TROFOLASTAT SAT-3247 OXALATE GSKVX000000070250 Finasteride A52 Zanubrutinib Abacavir Sulfate 2-DEOXY-D-GLUCOSE Pirfenidone Potassium Oxybate Imsidolimab Quercetin Depemokimab More therapies…

    Learn about Your Condition

    Gastric cancer recurrent Urticaria Procedural hypotension Intracranial aneurysm Microvillous inclusion disease Retinopathy of prematurity Round cell liposarcoma Endocarditis bacterial Colorectal adenocarcinoma Penile squamous cell carcinoma Erythema migrans Hypoxia Follicular lymphoma Obesity Narcolepsy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Glioblastoma

  • Study on Glioblastoma Treatment with Temozolomide, Lomustine, and Perflutren for Newly Diagnosed Patients

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Perflutren
    • Lomustine
    • Temozolomide
    Belgium France

  • Study of NMS-03305293 and Temozolomide for Adults with Recurrent Glioblastoma

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Nms-03305293
    • Temozolomide
    Italy The Netherlands

  • Study on the Safety of Photodynamic Therapy with Aminolevulinic Acid Hydrochloride for Patients Aged 18-75 with Grade IV Glioblastoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Malignant glioma
    • Glioblastoma
    Investigated Drugs:
    • Aminolevulinic Acid Hydrochloride
    France

  • Study of AGuIX Nanoparticles and Temozolomide with Radiotherapy for Patients with Newly Diagnosed Glioblastoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Glioblastoma
    France

  • Study on Durvalumab and Radiation Therapy for Patients with Recurrent Glioblastoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Durvalumab
    France

  • Study on the Effectiveness and Safety of a Vaccine with Dendritic Cells for Patients with Newly Diagnosed Glioblastoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Autologous Mature Dendritic Cells Loaded With Autologous Tumor Lysate
    Germany
Previous Page
1 … 3 4 5 6 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!